ARTICLE | Finance

First filing for 2012

First life sciences IPO filing of 2012 by diagnostics play Cancer Genetics

January 9, 2012 8:00 AM UTC

Cancer Genetics Inc. became the first life sciences company to file for an IPO in the New Year. The diagnostics company, which is seeking to raise up to $50 million, develops DNA probes using fluorescent in situ hybridization (FISH) and microarrays using comparative genomic hybridization.

Cancer Genetics has a CLIA-certified laboratory to perform its MatBA-CLL test, which identifies genomic markers associated with chronic lymphocytic leukemia (CLL) to help physicians diagnose the disease as well as determine treatment and prognosis...